The sustainability of a community pharmacy intervention to improve the quality use of asthma medication

Journal of Clinical Pharmacy and Therapeutics

Volumn 36, Issue 2, 2011, Pages 144-151

  Bereznicki, B ^a   Peterson, G ^a   Jackson, S ^a   Walters, E H ^b   Gee, P ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

asthma; community pharmacy; data mining; general practitioner referral; intervention; prescription records; sustainability

Indexed keywords

BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; FLUTICASONE; SALBUTAMOL; TERBUTALINE;

ARTICLE; ASTHMA; COMMUNITY CARE; COMMUNITY PROGRAM; COMPUTER PROGRAM; DATA MINING; DRUG UTILIZATION; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PHARMACY; PRESCRIPTION;

ANTI-ASTHMATIC AGENTS; ASTHMA; COMMUNITY PHARMACY SERVICES; DATA MINING; FOLLOW-UP STUDIES; HUMANS; PATIENT EDUCATION AS TOPIC; PHARMACIES; PRESCRIPTION DRUGS; PROGRAM EVALUATION; QUALITY IMPROVEMENT; SOFTWARE; TREATMENT OUTCOME;

EID: 79952268840     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2010.01165.x     Document Type: Article

References (28)

1. Masoli M, Fabian D, Holt S, Beasley R, (2004) The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy, 59, 469-478. (Pubitemid 38580764)
2. Bousquet J, Bousquet PJ, Godard P, Daures JP, (2005) The public health implications of asthma. Bulletin of the World Health Organisation, 83, 548-554. (Pubitemid 41003331)
3. Australian Centre for Asthma Monitoring (2007) Asthma in Australia: findings from the 2004-05 National Health Survey. AIHW cat. no. ACM 10. Canberra: Australian Institute of Health and Welfare. Available at: (accessed 16th July 2009).
4. National Asthma Council (2006) Asthma Management Handbook. South Melbourne: National Asthma Council Australia Ltd.
5. National Asthma Council Australia. Asthma cycle of care. Available at: (accessed 21st June 2009).
6. Weinberger M, Murray MD, Marrero DG, et al. (2002) Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. Journal of the American Medical Association, 288, 1594-1602.
7. Bereznicki BJ, Peterson GM, Jackson SL, Walters EH, Fitzmaurice KD, Gee PR, (2008) Data-mining of medication records to improve asthma management. Medical Journal of Australia, 189, 21-25.
8. Asthma Foundations Australia (2007) Asthma: the basic facts. Australian Government Department of Health and Ageing. Available at: (accessed 29th January 2009).
9. Bereznicki BJ, Peterson GM, Jackson SL, Walters H, Fitzmaurice K, Gee P, (2008) Pharmacist-initiated general practitioner referral of patients with suboptimal asthma management. Pharmacy World and Science, 30, 869-875.
10. Malinen A, Hedman J, Koskela T, Silvasti M, Toivanen P, (2000) Salbutamol via Easyhaler produces equivalent bronchodilation to terbutaline via Turbuhaler following inhalation of a single dose of equipotent beta(2)-sympathomimetic. Clinical Drug Investigation, 20, 165-171.
11. van Schayck CP, Donnell D, (2004) The efficacy and safety of QVAR (hydrofluoroalkane-beclomethasone dipropionate extrafine aerosol) in asthma (part 1): an update of clinical experience in adults. International Journal of Clinical Practice, 58, 678-688. (Pubitemid 39144583)
12. Niphadkar P, Jagannath K, Joshi JM, et al. (2005) Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study. Clinical Therapeutics, 27, 1752-1763. (Pubitemid 41815226)
13. Wales D, Makker H, Kane J, McDowell P, O'Driscoll BR, (1999) Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers. Chest, 115, 1278-1284. (Pubitemid 29230634)
14. Australian Government Department of Health and Ageing. Pharmaceutical Benefits Scheme. Available at: (accessed 4th November 2009).
15. Krauth J, (1988) Distribution-free statistics: an application-oriented approach. Amsterdam: Elsevier.
16. Munro BH, (2001) Statistical methods for health care research. Philadelphia: Lippincott.
17. Salamzadeh J, Wong IC, Hosker HS, Patel MG, Chrystyn H, (2005) The relationship between the quality of prescribing and practice appointment rates with asthma management data in those admitted to hospital due to an acute exacerbation. Respiratory Medicine, 99, 735-741. (Pubitemid 40631300)
18. Shelley M, Croft P, Chapman S, Pantin C, (2000) Is the quality of asthma prescribing, as measured by the general practice ratio of corticosteroid to bronchodilator, associated with asthma morbidity? Journal of Clinical Epidemiology, 53, 1217-1221. (Pubitemid 32007837)
19. Fuhlbrigge A, Carey VJ, Adams RJ, et al. (2004) Evaluation of asthma prescription measures and health system performance based on emergency department utilization. Medical Care, 42, 465-471.
20. Frischer M, Heatlie H, Chapman S, Bashford J, Norwood J, Millson D, (2000) Ratio of inhaled corticosteroid to bronchodilator treatment and asthma hospitalisation. Current Medical Research and Opinion, 16, 8-13. (Pubitemid 30107747)
21. Aveyard P, (1997) Assessing the performance of general practices caring for patients with asthma. British Journal of General Practice, 47, 423-426. (Pubitemid 27336304)
22. Hong SH, Sanders BH, West D, (2006) Inappropriate use of inhaled short acting beta-agonists and its association with patient health status. Current Medical Research and Opinion, 22, 33-40. (Pubitemid 43106905)
23. Schatz M, Zeiger RS, Vollmer WM, et al. (2006) Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data. Journal of Allergy and Clinical Immunology, 117, 995-1000.
24. Schatz M, Zeiger RS, Vollmer WM, et al. (2006) Development and validation of a medication intensity scale derived from computerized pharmacy data that predicts emergency hospital utilization for persistent asthma. American Journal of Managed Care, 12, 478-484. (Pubitemid 44267085)
25. Chen CH, Xirasagar S, Lin HC, (2006) Seasonality in adult asthma admissions, air pollutant levels, and climate: a population-based study. Journal of Asthma, 43, 287-292.
26. Pendergraft TB, Stanford RH, Beasley R, Stempel DA, McLaughlin T, (2005) Seasonal variation in asthma-related hospital and intensive care unit admissions. Journal of Asthma, 42, 265-271. (Pubitemid 40967718)
27. Schatz M, Zeiger RS, Vollmer WM, et al. (2006) The controller-to-total asthma medication ratio is associated with patient-centered as well as utilization outcomes. Chest, 130, 43-50. (Pubitemid 44116840)
28. Eisner MD, Lieu TA, Chi F, et al. (2001) Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma. European Respiratory Journal, 17, 233-240. (Pubitemid 32600582)